EMA/PE/0000234140 - paediatric investigation plan

denecimig

Key facts

• Active substance:
  denecimig
• Therapeutic area:
  Blood and lymphatic system disorders
• Decision number:
  EMA/PE/0000234140
• PIP number:
  EMA/PE/0000234140
• Pharmaceutical form(s):
  Solution for injection
• Condition(s) / indication(s):
  Treatment of Haemophilia A
• Route(s) of administration:
  Subcutaneous use
• Decision type:
  PM: decision on the application for modification of an agreed PIP
• Decision date:
  16/04/2025
• Compliance check done:
  No

Decision

EMA/PE/0000234140 : EMA decision of 16 April 2025 on the acceptance of a modification of an agreed paediatric investigation plan for denecimig

Adopted Reference Number: EMADOC-1700519818-2037954